SENSIPAR

This brand name is authorized in United States. It is also authorized in Canada, New Zealand, South Africa.

Active ingredients

The drug SENSIPAR contains one active pharmaceutical ingredient (API):

1	Cinacalcet UNII 1K860WSG25 - CINACALCET HYDROCHLORIDE
	Cinacalcet is a calcimimetic agent which directly lowers PTH levels by increasing the sensitivity of the calcium sensing receptor to extracellular calcium. The reduction in PTH is associated with a concomitant decrease in serum calcium levels.
	Read more about Cinacalcet

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SENSIPAR Coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
H05BX01	Cinacalcet	H Systemic hormonal preparations, excl. Sex hormones and insulins → H05 Calcium homeostasis → H05B Anti-parathyroid agents → H05BX Other anti-parathyroid agents
Discover more medicines within H05BX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02257130, 02257149, 02257157
NZ	Medicines and Medical Devices Safety Authority	11425, 11426, 11427
US	FDA, National Drug Code	50090-3529, 50090-4470, 55513-073, 55513-074, 55513-075
ZA	Health Products Regulatory Authority	42/21.12/0121, 42/21.12/0122, 42/21.12/0123